John Schembri

John Schembri, CEP, has extensive experience in finance and accounting, with notable positions at various biotechnology companies including Akero Therapeutics, Seer, and Global Blood Therapeutics. John also held executive roles at StemPar Sciences, BiPar Sciences, and Sirna Therapeutics, contributing to the success and growth of these organizations. Schembri's involvement in strategic financial planning, corporate strategy, and successful acquisitions demonstrates their strong leadership and finance expertise. John graduated from California Polytechnic State University with a Bachelor of Business Administration in Finance and Accounting.